Sebia partners with Inserm Transfert to develop a unique diagnostic test for haemoglobin diseases

Collaboration will focus mainly on the diagnosis of thalassaemias

11-Jun-2012 - Sebia announced that it has entered into partnership with Inserm (the French National Institute of Health and Medical Research) and Inserm Transfert, its private subsidiary responsible for marketing the outcomes of its scientific research, to develop and commercialize a unique biological test for ...

TcLand Expression signs a licensing agreement with Inserm Transfert

Strategic collaboration on the development of companion diagnostic tests for rheumatoid arthritis therapies

08-Jul-2010 - TcLand Expression SA announced the signature of a licensing agreement with Inserm Transfert. The terms of the agreement include the grant of worldwide, exclusive licenses to TcLand Expression for two different patents covering gene expression signatures which can predict responsiveness to ...

Inserm Transfert and Innate Pharma enter into a partnership for the development of antibodies for the treatment of cancer

14-Sep-2009 - Inserm Transfert and Innate Pharma announce the execution of an agreement facilitating the development of antibodies in cancer, inflammation and auto-immunity. This partnership of a new kind will enable Innate Pharma to be informed of the discovery of promising antibody targets at an early stage, ...